TY - JOUR
T1 - Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis
AU - Goldsammler, Michelle
AU - Merhi, Zaher
AU - Buyuk, Erkan
N1 - Publisher Copyright:
© 2018 The Author(s).
PY - 2018/5/9
Y1 - 2018/5/9
N2 - Background: Besides being a risk factor for multiple metabolic disorders, obesity could affect female reproduction. While increased adiposity is associated with hormonal changes that could disrupt the function of the hypothalamus and the pituitary, compelling data suggest that obesity-related hormonal and inflammatory changes could directly impact ovarian function. Objective: To review the available data related to the mechanisms by which obesity, and its associated hormonal and inflammatory changes, could affect the female reproductive function with a focus on the hypothalamic-pituitary-ovarian (HPO) axis. Methods: PubMed database search for publications in English language until October 2017 pertaining to obesity and female reproductive function was performed. Results: The obesity-related changes in hormone levels, in particular leptin, adiponectin, ghrelin, neuropeptide Y and agouti-related protein, are associated with reproductive dysfunction at both the hypothalamic-pituitary and the ovarian levels. The pro-inflammatory molecules advanced glycation end products (AGEs) and monocyte chemotactic protein-1 (MCP-1) are emerging as relatively new players in the pathophysiology of obesity-related ovarian dysfunction. Conclusion: There is an intricate crosstalk between the adipose tissue and the inflammatory system with the HPO axis function. Understanding the mechanisms behind this crosstalk could lead to potential therapies for the common obesity-related reproductive dysfunction.
AB - Background: Besides being a risk factor for multiple metabolic disorders, obesity could affect female reproduction. While increased adiposity is associated with hormonal changes that could disrupt the function of the hypothalamus and the pituitary, compelling data suggest that obesity-related hormonal and inflammatory changes could directly impact ovarian function. Objective: To review the available data related to the mechanisms by which obesity, and its associated hormonal and inflammatory changes, could affect the female reproductive function with a focus on the hypothalamic-pituitary-ovarian (HPO) axis. Methods: PubMed database search for publications in English language until October 2017 pertaining to obesity and female reproductive function was performed. Results: The obesity-related changes in hormone levels, in particular leptin, adiponectin, ghrelin, neuropeptide Y and agouti-related protein, are associated with reproductive dysfunction at both the hypothalamic-pituitary and the ovarian levels. The pro-inflammatory molecules advanced glycation end products (AGEs) and monocyte chemotactic protein-1 (MCP-1) are emerging as relatively new players in the pathophysiology of obesity-related ovarian dysfunction. Conclusion: There is an intricate crosstalk between the adipose tissue and the inflammatory system with the HPO axis function. Understanding the mechanisms behind this crosstalk could lead to potential therapies for the common obesity-related reproductive dysfunction.
KW - Advanced glycation end products
KW - HPO
KW - Monocyte chemotactic protein-1
KW - Obesity
KW - Ovary
UR - http://www.scopus.com/inward/record.url?scp=85046662400&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046662400&partnerID=8YFLogxK
U2 - 10.1186/s12958-018-0366-6
DO - 10.1186/s12958-018-0366-6
M3 - Review article
C2 - 29743077
AN - SCOPUS:85046662400
SN - 1477-7827
VL - 16
JO - Reproductive Biology and Endocrinology
JF - Reproductive Biology and Endocrinology
IS - 1
M1 - 45
ER -